Plasma peptidome pattern of breast cancer using magnetic beads-based plasma fractionation and MALDI-TOF MS: A case control study in Egypt

3Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Objective: The present study aimed to determine peptidome patterns in breast cancer (BC). Methods: We analyzed the plasma proteomic profiling of 80 BC patients and 50 healthy controls, using hydrophobic interaction chromatography magnetic beads (MB-HIC8) separation followed by Matrix assisted laser desorption ionization/ time of flight mass spectrometry (MALDI-TOF MS). Results: ClinProTools software identified 92 peaks that differed among the analyzed groups, 33 peaks were significantly different (P < 0.05). Of those, 22 peaks were up-regulated while 11 peaks were down-regulated in BC patients compared with the healthy controls. Three peptide ion signatures (m/z 1,570.31, 1,897.4 and 2,568.17) were provided by the Quick Classifier model to discriminate BC patients from healthy control subjects with 96.4% accuracy. External validation was performed by an independent group and this achieved a sensitivity of 100% and a specificity of 76.9%. Conclusion: MALDI-TOF MS has good analytical performance in distinguishing BC patients from healthy controls.

Cite

CITATION STYLE

APA

Zaki, A., Ramadan, R. A., Moez, P., Ghareeb, H., & Elkarmouty, A. (2019). Plasma peptidome pattern of breast cancer using magnetic beads-based plasma fractionation and MALDI-TOF MS: A case control study in Egypt. Asian Pacific Journal of Cancer Prevention, 20(1), 175–184. https://doi.org/10.31557/APJCP.2019.20.1.175

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free